AI assistant
Sending…
ADMA BIOLOGICS, INC. — Director's Dealing 2021
Oct 19, 2021
31261_dirs_2021-10-18_38d0746f-ecb2-4af7-b8bb-b23383be78b9.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: ADMA BIOLOGICS, INC. (ADMA)
CIK: 0001368514
Period of Report: 2021-10-15
Reporting Person: KWON YOUNG (N/A)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 100000 | Direct |
More from ADMA BIOLOGICS, INC.
Interim / Quarterly Report
2026
May 6
Regulatory Filings
2026
May 4
Annual Report
2026
Apr 15
Proxy Solicitation & Information Statement
2026
Apr 15
Regulatory Filings
2026
Mar 27
Major Shareholding Notification
2026
Mar 26
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 18
Director's Dealing
2026
Mar 3
Regulatory Filings
2026
Mar 2